结直肠癌的免疫疗法:从遗传遗传学的洞察力
Nijole Pollock Tjader1, Amanda Ewart Toland2
1Department of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Trends in cancer
|February 15, 2024
概括
免疫疗法对许多癌症有效,但对微卫星稳定的结直肠癌 (CRC) 不有效. 在CRC中遗传的遗传变异可能为这种常见的,不响应的癌症提供新的免疫治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 免疫疗法,特别是免疫检查点抑制剂 (ICI),在治疗各种癌症方面显示出显著的前景.
- 然而,微卫星稳定的结直肠癌 (CRC) 仍然在很大程度上对当前的ICI治疗无反应.
- 由于CRC的高发病率,开发新的免疫疗法策略至关重要.
研究的目的:
- 审查在结直肠癌中影响免疫系统的遗传遗传因素.
- 将这些遗传发现与目前和新兴的CRC免疫疗法方法联系起来.
主要方法:
- 对结直肠癌遗传研究的文献综述.
- 分析与CRC风险相关的遗传生殖系遗传变异.
- 探索与免疫功能相关的基因,包括MHC区域和细胞因子通路中的基因.
主要成果:
- 在CRC中遗传遗传变异的一个子集与免疫基因调节有关.
- 这些变异涉及与现有的ICI和潜在的新免疫疗法点相关的基因.
- 潜在的标包括主要组织相容性复合体 (MHC) 和免疫调节性细胞因子中的基因.
结论:
- 遗传遗传学为了解CRC的免疫疗法耐药性提供了一个框架.
- 识别基因变异可以揭示新的点,以提高不响应CRC的免疫疗法疗效.
- 未来的研究应该专注于利用这些遗传见解进行个性化CRC免疫疗法.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.7K
06:19Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
Published on: July 18, 2017
10.0K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K